Feedback / Questions
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Zynlonta (loncastuximab tesirine) - Overland ADCT BioPharma, Mitsubishi Tanabe, SOBI
https://www.businesswire.com/news/home/20220921005889/en/ADC-Therapeutics-Announces-Abstracts-to-be-Presented-at-the-Tenth-Annual-Meeting-of-the-Society-of-Hematologic-Oncology-SOHO-2022
Sep 21, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next